A longtime vaccine critic hired by Health Secretary RFK Jr is reviewing safety data in an effort to revisit debunked claims that vaccines may cause autism.

Dr L’Erario discusses neurologic care for TGD patients, highlighting key challenges, best practices, & steps toward more inclusive treatment.

The FDA has granted Fast Track designation to nadunolimab to treat patients with previously untreated metastatic pancreatic ductal adenocarcinoma.

In patients with moderate peripheral artery disease, use of GLP-1 RAs increases the likelihood of more favorable cardiovascular and major limb outcomes.

By including information on suicidal thoughts and behaviors, clinicians can greatly improve predictive accuracy via machine learning.

The Clinical Advisor spoke with Carlos Gutiérrez, EdD, MMS, PA-C, about the impact of Executive Orders on LGBTQ+ health care.

Here's what clinicians can do amidst the current social and political landscape to provide gender affirming healthcare for their patients.

Individuals with type 2 diabetes who receive treatment with GLP-1 RAs do not have an increased risk for acute pancreatitis.

Higher glycemia was associated with worse cognitive score outcomes among patients with short-duration type 2 diabetes at 4-year follow-up.

The Clinical Advisor spoke with NP Dallas Ducar about what clinicians can do amidst the current social and political landscape to adequately care for their transgender and gender-diverse patients.

When discussing fertility preservation options among transgender patients, it is critical to keep barriers to access in mind.

For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at 1 year is 8.7% on average.